- Home
- NDRA vs ONFO Comparison
NDRA vs ONFO Comparison
Compare NDRA & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- ONFO
- Stock Information
- Founded
- NDRA 2007
- ONFO 2018
- Country
- NDRA United States
- ONFO United States
- Employees
- NDRA N/A
- ONFO N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ONFO Computer Software: Programming Data Processing
- Sector
- NDRA Health Care
- ONFO Technology
- Exchange
- NDRA Nasdaq
- ONFO Nasdaq
- Market Cap
- NDRA 4.6M
- ONFO 5.0M
- IPO Year
- NDRA 2017
- ONFO 2022
- Fundamental
- Price
- NDRA $5.01
- ONFO $1.07
- Analyst Decision
- NDRA Strong Buy
- ONFO
- Analyst Count
- NDRA 1
- ONFO 0
- Target Price
- NDRA $38.00
- ONFO N/A
- AVG Volume (30 Days)
- NDRA 798.9K
- ONFO 104.0K
- Earning Date
- NDRA 11-14-2025
- ONFO 11-14-2025
- Dividend Yield
- NDRA N/A
- ONFO N/A
- EPS Growth
- NDRA N/A
- ONFO N/A
- EPS
- NDRA N/A
- ONFO N/A
- Revenue
- NDRA N/A
- ONFO $10,508,728.00
- Revenue This Year
- NDRA N/A
- ONFO N/A
- Revenue Next Year
- NDRA N/A
- ONFO N/A
- P/E Ratio
- NDRA N/A
- ONFO N/A
- Revenue Growth
- NDRA N/A
- ONFO 78.36
- 52 Week Low
- NDRA $2.90
- ONFO $0.61
- 52 Week High
- NDRA $12.49
- ONFO $1.95
- Technical
- Relative Strength Index (RSI)
- NDRA 41.38
- ONFO 47.62
- Support Level
- NDRA $4.58
- ONFO $1.00
- Resistance Level
- NDRA $5.43
- ONFO $1.26
- Average True Range (ATR)
- NDRA 0.69
- ONFO 0.08
- MACD
- NDRA -0.24
- ONFO 0.00
- Stochastic Oscillator
- NDRA 8.19
- ONFO 27.43
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.